Wall Street analysts expect Invitae Corporation (NYSE:NVTA) to post ($0.55) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Invitae Corporation’s earnings, with estimates ranging from ($0.70) to ($0.47). Invitae Corporation reported earnings per share of ($0.69) in the same quarter last year, which indicates a positive year over year growth rate of 20.3%. The company is scheduled to report its next earnings results on Monday, February 12th.
According to Zacks, analysts expect that Invitae Corporation will report full year earnings of ($2.45) per share for the current year, with EPS estimates ranging from ($2.58) to ($2.30). For the next financial year, analysts forecast that the company will post earnings of ($1.70) per share, with EPS estimates ranging from ($1.99) to ($1.38). Zacks’ earnings per share calculations are an average based on a survey of analysts that follow Invitae Corporation.
NVTA has been the topic of several analyst reports. BidaskClub raised Invitae Corporation from a “hold” rating to a “buy” rating in a report on Thursday, October 12th. Zacks Investment Research raised Invitae Corporation from a “sell” rating to a “hold” rating in a report on Friday, August 11th. Leerink Swann dropped their target price on Invitae Corporation from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. Finally, J P Morgan Chase & Co reaffirmed an “overweight” rating and set a $15.00 target price (up from $14.00) on shares of Invitae Corporation in a report on Wednesday, August 9th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. Invitae Corporation has an average rating of “Hold” and a consensus target price of $13.50.
Shares of Invitae Corporation (NYSE:NVTA) opened at $8.39 on Tuesday. Invitae Corporation has a 1-year low of $2.35 and a 1-year high of $8.46. The company has a quick ratio of 2.61, a current ratio of 2.61 and a debt-to-equity ratio of 0.33.
Invitae Corporation Company Profile
Invitae Corporation utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Invitae Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae Corporation and related companies with MarketBeat.com's FREE daily email newsletter.